Dies ist eine Übersichtsseite mit Metadaten zu dieser wissenschaftlichen Arbeit. Der vollständige Artikel ist beim Verlag verfügbar.
2010 Rheumatoid arthritis classification criteria: An American College of Rheumatology/European League Against Rheumatism collaborative initiative
9.516
Zitationen
35
Autoren
2010
Jahr
Abstract
OBJECTIVE: The 1987 American College of Rheumatology (ACR; formerly, the American Rheumatism Association) classification criteria for rheumatoid arthritis (RA) have been criticized for their lack of sensitivity in early disease. This work was undertaken to develop new classification criteria for RA. METHODS: A joint working group from the ACR and the European League Against Rheumatism developed, in 3 phases, a new approach to classifying RA. The work focused on identifying, among patients newly presenting with undifferentiated inflammatory synovitis, factors that best discriminated between those who were and those who were not at high risk for persistent and/or erosive disease--this being the appropriate current paradigm underlying the disease construct "rheumatoid arthritis." RESULTS: In the new criteria set, classification as "definite RA" is based on the confirmed presence of synovitis in at least 1 joint, absence of an alternative diagnosis that better explains the synovitis, and achievement of a total score of 6 or greater (of a possible 10) from the individual scores in 4 domains: number and site of involved joints (score range 0-5), serologic abnormality (score range 0-3), elevated acute-phase response (score range 0-1), and symptom duration (2 levels; range 0-1). CONCLUSION: This new classification system redefines the current paradigm of RA by focusing on features at earlier stages of disease that are associated with persistent and/or erosive disease, rather than defining the disease by its late-stage features. This will refocus attention on the important need for earlier diagnosis and institution of effective disease-suppressing therapy to prevent or minimize the occurrence of the undesirable sequelae that currently comprise the paradigm underlying the disease construct "rheumatoid arthritis."
Ähnliche Arbeiten
The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis
1988 · 19.899 Zit.
Validation study of WOMAC: a health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee.
1988 · 7.827 Zit.
Revised Criteria for the Classification of Rheumatoid Arthritis
1990 · 7.735 Zit.
Development of criteria for the classification and reporting of osteoarthritis: Classification of osteoarthritis of the knee
1986 · 6.762 Zit.
Modified disease activity scores that include twenty-eight-joint counts development and validation in a prospective longitudinal study of patients with rheumatoid arthritis
1995 · 6.208 Zit.
Autoren
- Daniel Aletaha
- Tuhina Neogi
- Alan J. Silman
- Julia Funovits
- David T. Felson
- Clifton O. Bingham
- Neal S. Birnbaum
- Gerd R Burmester
- Vivian P. Bykerk
- Marc D. Cohen
- Bernard Combe
- Karen H. Costenbader
- Maxime Dougados
- Paul Emery
- Gianfranco Ferraccioli
- Johanna M. W. Hazes
- Kathryn Hobbs
- T. Huizinga
- Arthur Kavanaugh
- Jonathan Kay
- Tore K. Kvien
- Timothy Laing
- Philip J. Mease
- Henri A. Ménard
- Larry W. Moreland
- Raymond L. Naden
- Theodore Pincus
- Josef S Smolen
- Ewa Stanisławska‐Biernat
- Deborah Symmons
- Paul P. Tak
- Katherine S. Upchurch
- Jiří Vencovský
- Frederick Wolfe
- Gillian Hawker
Institutionen
- Bristol-Myers Squibb (Germany)(DE)
- Medical University of Vienna(AT)
- Boston University(US)
- Roche (Switzerland)(CH)
- Johns Hopkins University(US)
- Merck Serono S.A. (Switzerland)(CH)
- Bristol-Myers Squibb (Switzerland)(CH)
- University of California, San Francisco(US)
- California Pacific Medical Center(US)
- Agence pour le Développement et la Réhabilitation de la Ville de Fès(MA)
- Humboldt-Universität zu Berlin(DE)
- Charité - Universitätsmedizin Berlin(DE)
- Mount Sinai Hospital(CA)
- Amgen (United States)(US)
- University of Toronto(CA)
- Abbott (United Kingdom)(GB)
- Employment Agency(BG)
- National Jewish Health(US)
- University of Colorado Denver(US)
- Bristol-Myers Squibb (United States)(US)
- Brigham and Women's Hospital(US)
- Harvard University(US)
- Délégation Paris 5(FR)
- Université Paris Cité(FR)
- Hôpital Cochin(FR)
- Assistance Publique – Hôpitaux de Paris(FR)
- University of Leeds(GB)
- NIHR Leeds Musculoskeletal Biomedical Research Unit(GB)
- Università Cattolica del Sacro Cuore(IT)
- Technology Holding (United States)(US)
- Erasmus MC(NL)
- Leiden University Medical Center(NL)
- University of California San Diego(US)
- University of Massachusetts Chan Medical School(US)
- UMass Memorial Medical Center(US)
- Diakonhjemmet Hospital(NO)
- University of Michigan(US)
- University of Washington(US)
- Swedish Medical Center(US)
- Mercedes-Benz (Germany)(DE)
- Merck KGaA, Darmstadt (Germany)(DE)
- Pfizer (United States)(US)
- McGill University Health Centre(CA)
- Merck B.V. (Netherlands)(NL)
- Immune Regulation (United Kingdom)(GB)
- University of Pittsburgh(US)
- PhytoCeutica (United States)(US)
- Ministry of Health(NZ)
- School for Advanced Research(US)
- New York University Langone Orthopedic Hospital(US)
- National Institute of Geriatrics, Rheumatology and Rehabilitation(PL)
- University of Manchester(GB)
- Amsterdam UMC Location University of Amsterdam(NL)
- University of Amsterdam(NL)
- Institute of Rheumatology(CZ)
- University of Kansas(US)
- The National Databank for Rheumatic Diseases(US)
- Women's College Hospital(CA)